Autopsy report · NCT05456360

Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project

“Poor accrual and poor patient engagement with survey completion”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 8 months before it stopped.
• 89 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Sleep

Interventions

ViSi Mobile device; Sleep enhancement intervention

Participants

89

Sites

1

Countries

United States

Trials that died the same way

• Abiraterone-Rechallenge Study for CRPC Patients
  “Lack of Patient accrual” (64% match in meaning)
• Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
  “Insufficient patient participation” (64% match in meaning)
• Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
  “Inadequate patient accrual” (62% match in meaning)
• SOX as Salvage Treatment in Nasopharyngeal Carcinoma
  “poor accrual of eligible patients” (62% match in meaning)
• Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
  “Lack of patient accruals.” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.